Richman Chemical to Attend the 2016 DIA Annual Meeting in Philadelphia, PA

Philadelphia, Pa, May 23, 2016-- Richman Chemical, Inc. will attend the 2016 DIA Annual Meeting taking place in Philadelphia June 27-29, 2016 at the Pennsylvania Convention Center.

This years Drug Information Association (DIA) Annual Meeting is anticipated to have over 7,000 attendees for what is described as the largest global interdisciplinary event.  This conference will bring together key thought leaders and innovators across all disciplines involved in the discovery, development, and life cycle management of health care products; such as:

  • Industry
  • Academia
  • Regulatory and Government Agencies
  • Global Health, Patient and Philanthropic Organizations

For more information on the conference visit

About Richman Chemical

For over 28 years, Richman Chemical Inc. (RCI) has provided contract R&D, custom synthesis of materials for pre-clinical and toxicology studies, and cGMP-compliant (API, drug product) clinical and commercial manufacture for emerging technology and life science markets, including pharmaceuticals, biotech, and medical device customers. Founded in 1988 by Dr. Ed Richman, the company is headquartered outside of Philadelphia. 

Click here to view all Richman Chemical press releases.

For more information follow us on LinkedIn.

Press Release Contact:

Christopher Kulp
Executive Vice President
Richman Chemical Inc.
Office: (215) 628-2946 Ext. 13